date:Feb 21, 2014
opped the 4.6 percent achieved by Swiss rival Nestle.
The Medical Nutrition business showed 6.4 percent growth in the fourth quarter after a 5.6 percent growth in the third.
Reuters reported last week that Danone was mulling its sale as it expands its dairy business in higher-growth emerging markets. Terisse declined to comment on Thursday. .
The stock trades at 17.57 times 12-month forward earnings, against 18.75 times for Nestle and 17.42 times for Unilever.